Phibro Animal Health Corporation (PAHC) Q4 2026 Earnings Call Transcript

SA Transcripts 162.03K Followers Follow Phibro Animal Health Corporation ( PAHC ) Q4 2026 Earnings Call August 27, 2026 9:00 AM EDT Company Participants Glenn David - Chief Financial Officer Daniel Bendheim - CEO, President & Director Larry Miller - Chief Operating Officer Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Daniel Grosslight - Citigroup Inc., Research Division Michael Ryskin - BofA Securities, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Presentation Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Phibro Animal Health Corporation Fourth Quarter 2026 Conference Call. [Operator instructions] I would now like to turn the conference over to Glenn David, Chief Financial Officer. Please go ahead. Glenn David Chief Financial Officer Thank you, Regina. Good day, and welcome to the Phibro Animal Health Corporation Earnings Call for our fiscal fourth quarter and full year ended June 30, 2026. My name is Glenn David, and I'm the Chief Financial Officer of Phibro Animal Health Corporation. I am joined on today's call by Dani Bendheim, President and Chief Executive Officer; and Larry Miller, Chief Operating Officer. Today, we will cover financial performance for our fourth quarter and full year 2026 and provide financial guidance for our fiscal year ending June 30, 2027. At the conclusion of our remarks, we will open the lines for your questions. I would like to remind you that we are providing a simultaneous webcast of this call on our website, pahc.com. Also, on the Investors section of our website, you will find copies of the earnings press release and annual Form 10-K as well as the transcript and slides discussed and presented on this call. Our remarks today